Our blog

Will Covid-19 increase US biosimilar adoption in 2021?
Will Covid-19 increase US biosimilar adoption in 2021?
by Ben Conway
Posted in Pharmaceuticals
In 2019, the US biosimilar market was worth $737.2 million and continues to grow with a CAGR of 46.2% forecast for 2020-2027, however many are frustrated at the current rate of adoption in the US. But with increasing healthcare costs and a growing debt from Covid-19, what does the next year hold for biosimilar adoption across the US?
Read more
Interview with Rachel McNeill | Founder & CEO | PharmaPhix
Interview with Rachel McNeill | Founder & CEO | PharmaPhix
by Christine Sands
Posted in Female Leaders, Pharmaceuticals
As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Rachel McNeill – Founder & CEO at PharmaPhix – about her new pharma services company and why she feels society’s biggest challenge is accepting that we all have an equal role in balancing work and family life regardless of gender.
Read more
Interview with Emmanuelle Lepine | General Manager | mAbxience
Interview with Emmanuelle Lepine | General Manager | mAbxience
by Christine Sands
Posted in Female Leaders, Pharmaceuticals
As part of our ‘Female Leaders: Inspiring Together series, we interviewed Emmanuelle Lepine – General Manager at mAbxience – about becoming a CEO of a pharma company before the age of 40 and how she learnt the hard way not to push yourself past your limits.
Read more
Interview with Berit Lindholm | CEO | Bluefish Pharmaceuticals
Interview with Berit Lindholm | CEO | Bluefish Pharmaceuticals
by Christine Sands
Posted in Female Leaders, Pharmaceuticals
As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Berit Lindholm – CEO for Bluefish Pharma – about how she started her career in pharmaceuticals, her greatest achievements and why she initially turned down a CEO role.
Read more